Maprelin 75 µg/ml solution for injection for pigs
Maprelin 75 µg/ml solution for injection for pigs
Authorised
- Peforelin
Product identification
Medicine name:
Maprelin 75 µg/ml solution for injection for pigs
MAPRELIN 75 ΜG/ML SOLUTION INJECTABLE POUR PORCS
Active substance:
- Peforelin
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Peforelin75.00microgram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Pig
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH01CA95
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Available in:
-
France
Package description:
- (ID4) 100 millilitre(s): unspecified outer container with 1 Vial (Glass) with 100 millilitre(s)
- (ID3) 50 millilitre(s): unspecified outer container with 1 Vial (Glass) with 50 millilitre(s)
- (ID2) 60 millilitre(s): unspecified outer container with 6 Vial (Glass) each with 10 millilitre(s)
- (ID1) 10 millilitre(s): unspecified outer container with 1 Vial (Glass) with 10 millilitre(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Veyx Pharma GmbH
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/9766328 9/2009
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0129/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Czechia
-
Estonia
-
France
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 14/02/2022
French (PDF)
Published on: 4/04/2022
How useful was this page?: